Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

DEARhealth Becomes One Of The World’s First Companies To Obtain CE-marking According To New European Union Medical Device Regulation (MDR)

DEARhealth, a health tech company focused on AI-powered chronic disease management, announced that it has obtained certification for ISO and the certificate of conformity according to the European Union Medical Device Regulation (MDR) as a class IIa medical device for the first release of the DEARhealth patient and care software. With this certification, DEARhealth has demonstrated the ability to build, maintain, and manage the complete lifecycle of a software as a medical device. The CE-mark allows DEARhealth to market its medical software commercially in the European Union.

Recommended AI News: Xfinite and Eros Now Expand Partnership for Blockchain-Based Content Engagement Program on Algorand

CE-marking according to MDR assures health systems and pharmaceutical companies that a software as a medical device complies to European Union regulation and meets a high standard of quality and safety requirements.

Related Posts
1 of 40,385

“Worldwide, MDR is the most rigorous regulation for medical software,” said Daniel Hommes, DEARhealth Founder and Chief Medical and Product Officer. “Our partners in both the US and Europe can be confident that we design and manufacture our medical device software under high standards of quality and safety. DEARhealth validated remarkable health outcomes and efficiencies as clinical evidence to demonstrate conformity to the regulatory requirements.”

Following a successful conformity assessment, including an audit of the quality management system, DEARhealth is among the first 250 manufacturers to obtain CE-marking according to MDR for their medical device software.

“We’re very proud to obtain CE-marking in such a short time, which is an incredible achievement,” said Katinka de Korte, DEARhealth’s Person Responsible for Regulatory Compliance. “Obtaining the CE-mark and certification for ISO 13485 enables DEARhealth to accelerate collaboration with health systems across Europe.”

Recommended AI News: HiOperator Accelerates Growth Through Dallas Expansion And Amplifies Customer Service Offerings

Comments are closed.